Healthcare

Global Deep Brain Stimulation Growth Opportunities

Exploration of New Clinical Applications Drive Future Growth Potential

INDUSTRY
Healthcare

RELEASE DATE
22-Apr-2022
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
K712-01-00-00-00
SKU
HC03533-GL-MT_26466
Yes
SHARE

Global Deep Brain Stimulation Growth Opportunities
Published on: 22-Apr-2022 | SKU: HC03533-GL-MT_26466

Need more details?

$2,450.00

$1,837.50 save 25 %

DownloadLink
Need more details?

Deep brain stimulation (DBS) therapies target a growing number of existing indications, including movement disorders and neuropsychiatric conditions, and newer areas such as lifestyle disorders, including diabetes and obesity. This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute to 6.3% of the global disease burden and are among the major causes of mortality (as high as 16% in low- and middle-income countries). There is increasing awareness of the need for long-term solutions to improve overall brain health and associated neurological symptoms. Greater awareness will be important to boost the adoption of DBS solutions. Non-invasive access options, robot-assisted implantation, artificial intelligence, and state-of-the-art device design are among the technological advances expected to improve therapy efficiency and safety, rapidly accelerating DBS to become the standard of care. The study assesses the current market status and innovations in DBS technologies. Considering the overall DBS market trend toward precision, personalized, and remote care, the report highlights the top 3 growth opportunities in the space for medical device and technology companies to target.

Author: Kaustubh Suresh Savant

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Deep Brain Stimulation Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Deep Brain Stimulation Segmentation

Growth Drivers for Deep Brain Stimulation

Growth Restraints for Deep Brain Stimulation

Global Burden of Deep Brain Stimulation Treated Indications

Global Burden of Deep Brain Stimulation Treated Indications (continued)

Evolution of Deep Brain Stimulation Therapy

DBS Therapy at Different Approval Stages for Different Indications

Competitor Ecosystem and Recent Development Activities

Key Competitors’ Product Portfolio

Digital Innovation Enabling Future Shift to Personalized and Remote Care

Supporting Digital Technologies Boost DBS Therapy Adoption

Key Takeaway—Top 5 Findings

Growth Opportunity 1—Integrating Digital Solutions for Patient-focused Care

Growth Opportunity 1—Integrating Digital Solutions for Patient-focused Care (continued)

Growth Opportunity 2—Facilitating Service Requirements to Expand into Developing Markets

Growth Opportunity 2—Facilitating Service Requirements to Expand into Developing Markets (continued)

Growth Opportunity 3—New Technology Research Focus to Gain Market Disruption Advantage

Growth Opportunity 3—New Technology Research Focus to Gain Market Disruption Advantage (continued)

List of Exhibits

Legal Disclaimer

List of Figures
  • Deep Brain Stimulation: Growth Drivers, Global, 2022–2026
  • Deep Brain Stimulation: Growth Restraints, Global, 2022–2025
  • Deep Brain Stimulation: Distribution Potential by Patient, Global, 2020
  • Deep Brain Stimulation: Therapy Evolution

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

19 Nov 2026   |   Global   |   Technology Research

Programmable Vaccines: AI-Designed Antigens and Next-Generation Rapid Platforms

Traditional vaccine development is an empirical, time-consuming process that often leads to a high failure rate. With the proven clinical success of RNA vaccines, there has been a focus on accelerating the development of vaccines to address the growing incidence of infectious diseases and emerging p...

17 Nov 2026   |   Global   |   Frost Radar

Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026

Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...

16 Nov 2026   |   North America   |   Frost Radar

Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026

This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...

03 Nov 2026   |   North America   |   Market Research

Enterprise Imaging Market, United States, 2025–2030

Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...

02 Nov 2026   |   Global   |   Market Research

Continuous Glucose Monitoring Market, Global, 2026

The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.